Analytical Data
-
Gene name
LMO1
- Application
-
Alternative Names
LMO1;RBTN1;RHOM1;TTG1;Rhombotin-1
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P25800
-
Expression Region
1-156aa
-
AA Sequence
MGSSHHHHHH SSGLVPRGSH MGSMMVLDKE DGVPMLSVQP KGKQKGCAGC NRKIKDRYLL KALDKYWHED CLKCACCDCR LGEVGSTLYT KANLILCRRD YLRLFGTTGN CAACSKLIPA FEMVMRARDN VYHLDCFACQ LCNQRFCVGD KFFLKNNMIL CQMDYEEGQL NGTFESQVQ
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
LMO1 (LIM domain only 1) is a member of the LIM domain protein family, which is characterized by the presence of LIM domains that are involved in protein-protein interactions and play crucial roles in various biological processes, including gene regulation, cellular signaling, and development. Recent studies have highlighted LMO1's significant role in hematopoiesis and its association with certain cancers, such as T-cell acute lymphoblastic leukemia (T-ALL). The dysregulation of LMO1 expression has been linked to oncogenic processes, making it a potential target for therapeutic interventions. Furthermore, LMO1 participates in the formation of protein complexes that regulate gene expression, suggesting its involvement in the development of specific tissues and organs. The production of recombinant LMO1 protein is essential for understanding its structural and functional properties, and for elucidating the molecular mechanisms by which it contributes to cell differentiation and malignancy. Research aimed at characterizing LMO1 through recombinant techniques can provide insights into its physiological functions and its potential as a biomarker or therapeutic target in cancer and other diseases.
